We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

5th Circ. Affirms Toss Of FCA Suit Against AndroGel Maker

Law360, New York (September 13, 2017, 2:03 PM EDT) -- The Fifth Circuit on Tuesday affirmed a lower court’s decision to toss allegations that Solvay Pharmaceuticals Inc. caused health care providers to wrongfully bill the government for three of its drugs in violation of the False Claims Act, saying the relators didn’t offer sufficient evidence to back their claims.

A three-judge panel ruled that relators John King and Tammy Drummond failed to prove that they were the original source of allegations against Solvay’s AndroGel drug and lacked evidence that the alleged off-label marketing of the company's Luvox and Aceon drugs...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

John King, et al v. Solvay SA


Case Number

16-20259

Court

Appellate - 5th Circuit

Nature of Suit

1890 Other Statutory Actions

Date Filed

April 26, 2016

Law Firms

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.